Long-term preventive therapy can keep people with hereditary angioedema (HAE) free from swelling attacks requiring treatment for extended periods, according to a real-world study in Germany that found that more than one-third of HAE patients on prophylactic meds had no attacks needing on-demand treatment for at least one year.
Discussion
Note: This column describes the author’s own experiences with various angioedema medications and thoughts about gene therapy. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. Gene therapy is a hot topic in medicine these days. It can be exciting as…
Discussion
The experimental therapy barzolvolimab can reduce disease activity in people with chronic spontaneous urticaria (CSU) — an inflammatory disorder characterized by recurrent itching and hives — who experience angioedema, according to results from two Phase 3 clinical trials. Celldex Therapeutics, the company developing barzolvolimab, plans to use the…
Discussion
Dawnzera (donidalorsen), a preventive therapy used to reduce the risk of swelling attacks in people with hereditary angioedema (HAE), has been approved in Canada for adults and adolescents ages 12 and older. The decision by Health Canada follows Dawnzera’s approval for the same indication in the U.S. last…
Angioedema is the formal medical term for swelling under the skin. It usually occurs as part of an allergic reaction, but has forms that are not due to allergies.
Acute angioedema often occurs as part of an allergic reaction to various allergens or triggers. These can include certain foods, insect bites or stings, medications, and natural rubber products like latex.
Angioedema and hives often occur at the same time. However, angioedema causes large, thick welts which may not be itchy, whereas hives are smaller and usually itchy.
Get regular updates to your inbox.
